Unlike in invertebrates, vertebrate Hox gene clusters are found in multiple copies and are tightly packed and organized, with all transcripts encoded by the same DNA strand. This vertebrate genomic synapomorphy was initially proposed as a conjectural principle and largely verified by recent genome sequencing efforts and an exception to this rule has not been reported thus far. This evolutionary conundrum can be tentatively explained when considering recent work on the various regulatory strategies implemented by these genomic loci. By using recent data addressing these issues, I will propose a model for this surprising observation.
This model is largely based upon the existence of flanking regulatory landscapes, rich in potent enhancers that regulate several Hox genes at once and which imposes several constrains to the transcriptional organization of these loci. Experiments will be described where such a tight genomic organization is modified Genetic, molecular and cellular studies have provided a blueprint of organogenesis for the mouse kidney. Several recent approaches have documented the generation of kidney-like structures from human pluripotent stem cell types. The translational drive to use these human kidney organoids for disease modelling and therapeutic intervention highlights a poor understanding of the normal processes and cell types generated in human kidney development. To this end, we are engaged in a detailed analysis of human kidney development, comparing mouse and human programs, and in vitro and in vivo processes. Mechanistic differences in mouse and human, and in vivo and in vitro, developmental processes will be discussed in the context of our human kidney studies. A mRNA modification contribute to molecular control of plant development. In this talk, I will discuss how FKBP12 INTERACTING PROTEIN 37 KD (FIP37), a core component of the plant m 6 A methyltransferase complex, serves as a novel master regulator that determines shoot stem cell fate in Arabidopsis through mediating m 6 A RNA modification and the resulting mRNA decay of key shoot meristem regulators. We rescued embryonic lethality of fip37 null mutants by embryo-specific expression of FIP37, and found that the mutants lacking FIP37 at the post-embryonic stage exhibit massive overproliferation of shoot apical meristems and fail to generate the above-ground tissues. Subsequent analyses of fip37 null mutants using RNA-seq and transcriptome-wide profiling of m Mutations in core cardiac transcription factors, including NKX2-5, GATA4, TBX5/20, are found commonly in familial cases of congenital heart disease (CHD). We have adapted the technique of DNA adenine methyltransferase identification (DamID), first used in whole Drosophila to identify targets of chromatin-binding proteins, to profile the targets of cardiac transcription factors (TF) in the cardiomyocyte HL1 cell line. DamID is complementary to chromatin immunoprecipitation (ChIP) but avoids artefacts associated with chromatin crosslinking and poor quality ChIP antibodies. Focusing on the targets of WT NKX2-5 and mutant proteins causative for CHD, we made the discovery that mutant proteins, even those lacking DNA binding ability, bind to a subset of normal targets as well as hundreds of unique targets termed "offtargets". Mutant proteins bind to targets and off-targets via their ability to dimerise with WT NKX2-5 and to broadly or ubiquitously-expressed NKX2-5 cofactors. Different mutants have distinct target and off-target signatures. Altered DNA binding specificity has also been documented. From genome-wide DamID data, machine-learning approaches have allowed us to identify previously unknown directly-interacting NKX2-5 cofactors. In an embryonic stem cell assay, expression of mutant NKX2-5 proteins can affect the expression of off-target genes. Our studies have implications for transcription factor function and the mechanism of CHD. We predict that mutation-specific dominant-negative and gainof-function effects arising from dysregulation of the hundreds of offtargets will destabilise the cardiac gene regulatory network and contribute to CHD pathophysiology. Genome-wide target data may allow classification of CHD phenotypes and long-term prognosis for CHD patients. This concept is broadly applicable to other diseases caused by TF mutations including cancer.
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